LATE-BREAKING CLINICAL TRIALS | CORONARY

Saturday, March 8, 2025

2:15 PM - 3:30 PM ET

Moderator(s)

Gregg W. Stone, MD, FACC, MSCAI

Physician
Mount Sinai
New York, New York, United States

Disclosure information not submitted.

Panelist(s)

Bernardo Cortese, MD, FESC, FSCAI

Director of Coronary Program
University Hospitals
Cleveland, Ohio, United States

No relationships to disclose
Suzanne J. Baron, MD, MSc

Interventional Cardiologist
Massachusetts General Hospital
Winchester, Massachusetts, United States

No relationships to disclose
Sukhdeep S. Bhogal, MD

Interventional Cardiologist
Sovah Health
Roanoke, Virginia, United States

No relationships to disclose
AC

Alaide Chieffo, MD

Professor of Cardiology
Vita Salute San Raffaele University - San Raffaele Scientific Institute
Milan, Lombardia, Italy

Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Abiomed Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Boheringer Ingelheim: Consulting Fees (e.g., advisory boards) (Ongoing); Cordis, Endovascular Division: Consulting Fees (e.g., advisory boards) (Terminated); Penumbra, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing)
James B. Hermiller, MD, FACC, MSCAI

Director Interventional Cardiology
St. Vincent Medical Group
Indianapolis, Indiana, United States

No relationships to disclose
Timir Paul, MD, PhD, FACC, FSCAI

Professor of Medicine; Program Director, Cardiovascular Disease Fellowship
University of Tennessee Health Science Center- Nashville, Ascension St. Thomas Hospital
Brentwood, Tennessee, United States

No relationships to disclose

Disclosure(s):

Gregg W. Stone, MD, FACC, MSCAI: Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave: Research support to Mount Sinai Hospital (Ongoing); Apollo Therapeutics, Cardiac Success, Occlutech, Millennia Biopharma, RCE, Ablative Solutions, Abbott: Consultant (Terminated); Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave, Biosense-Webster, Bioventrix: Research support to Mount Sinai Hospital (Terminated); Valfix, Zoll, HeartFlow, Shockwave, Ancora, Impulse Dynamics, Adona Medical, Oxitope, HighLife, Elixir, Elucid Bio, Aria, Alleviant, FBR Medical: Consultant (Ongoing)

Bernardo Cortese, MD, FESC, FSCAI: Acrostak: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Angiodynamics/Auryon: Consulting Fees (e.g., advisory boards) (Ongoing); ANT: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BBraun: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Biotronik: Grant/Research Support (Ongoing); Brosmed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cardionovum: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Concept Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cordis Inc.: Consultant (Ongoing); iVascular: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MedAlliance: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Suzanne J. Baron, MD, MSc: Abiomed Inc: Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Janssen: Consultant (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PiCardia: Consultant (Ongoing); Shockwave Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Sukhdeep S. Bhogal, MD: No financial relationships to disclose

Alaide Chieffo, MD: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Abiomed Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Boheringer Ingelheim: Consulting Fees (e.g., advisory boards) (Ongoing); Cordis, Endovascular Division: Consulting Fees (e.g., advisory boards) (Terminated); Penumbra, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing)

James B. Hermiller, MD, FACC, MSCAI: Abbott Vascular, Edwards: Consultant (Ongoing)

Timir Paul, MD, PhD, FACC, FSCAI: No financial relationships to disclose